Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Valvular Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 122 articles: HTML format

Single Articles

July 2025
1. TOMSIC A, Velders BJJ, Kawczynski MJ, Schoones JW, et al
   Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts.
   Heart. 2025 Jul 8:heartjnl-2025-326162. doi: 10.1136/heartjnl-2025-326162.
   PubMed     Abstract available
   
   
   June 2025
2. LIM HJ, Kim K, Gwak SY, Lee HJ, et al
   Early predictors of aortic valve surgery in patients with significant bicuspid aortic regurgitation without initial surgical indication.
   Heart. 2025 Jun 20:heartjnl-2025-325892. doi: 10.1136/heartjnl-2025-325892.
   PubMed     Abstract available
   
   
   
3. FALK V
   60: 'the magic number of greatness' in minimally invasive mitral valve repair?
   Heart. 2025 Jun 20:heartjnl-2025-326326. doi: 10.1136/heartjnl-2025-326326.
   PubMed    
   
   
   
4. KASSAR M, Gercek M, Rudolph V
   Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice.
   Heart. 2025 Jun 15:heartjnl-2024-325621. doi: 10.1136/heartjnl-2024-325621.
   PubMed    
   
   
   
5. HEUTS S, Kawczynski MJ, Maesen B, Vriesendorp PA, et al
   When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.
   Heart. 2025 Jun 10:heartjnl-2025-326208. doi: 10.1136/heartjnl-2025-326208.
   PubMed     Abstract available
   
   
   May 2025
6. SUN Y, Wang C, Li J, Luo S, et al
   Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
   Heart. 2025 May 10:heartjnl-2024-324697. doi: 10.1136/heartjnl-2024-324697.
   PubMed     Abstract available
   
   
   
7. NAKASE M, Draxler DF, Tomii D, Heg D, et al
   Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement.
   Heart. 2025 May 10:heartjnl-2024-325359. doi: 10.1136/heartjnl-2024-325359.
   PubMed     Abstract available
   
   
   
8. HEUTS S, Hjij W, Kawczynski MJ, Olsthoorn JR, et al
   Defining centres of expertise for minimally invasive mitral valve surgery: a systematic review and volume-outcome meta-analysis.
   Heart. 2025 May 10:heartjnl-2024-325048. doi: 10.1136/heartjnl-2024-325048.
   PubMed     Abstract available
   
   
   April 2025
9. WANG C, Hamid N, Bapat V, Cavalcante JL, et al
   Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
   Heart. 2025 Apr 30:heartjnl-2024-325194. doi: 10.1136/heartjnl-2024-325194.
   PubMed     Abstract available
   
   
   
10. MCCANN GP, Newby DE, Hillis GS
    TAVI for asymptomatic aortic stenosis? More compelling outcome data are needed.
    Heart. 2025 Apr 15:heartjnl-2025-325767. doi: 10.1136/heartjnl-2025-325767.
    PubMed    
    
    
    March 2025
11. CELMETA B, Miceli A
    Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key.
    Heart. 2025 Mar 23:heartjnl-2024-325410. doi: 10.1136/heartjnl-2024-325410.
    PubMed    
    
    
    
12. GEERS J, Manral N, Razipour A, Park C, et al
    Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
    Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925.
    PubMed     Abstract available
    
    
    
13. PANG L, Xia Y, Tang M, Ma M, et al
    Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
    Heart. 2025 Mar 3:heartjnl-2024-325221. doi: 10.1136/heartjnl-2024-325221.
    PubMed     Abstract available
    
    
    February 2025
14. LEE HJ, Gwak SY, Kim K, Cho I, et al
    Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy.
    Heart. 2025;111:253-261.
    PubMed     Abstract available
    
    
    
15. LIND V, Lundman P, Friberg L, Talback M, et al
    Dysglycaemia and incident aortic stenosis: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325150. doi: 10.1136/heartjnl-2024-325150.
    PubMed     Abstract available
    
    
    
16. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    PubMed    
    
    
    
17. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    PubMed     Abstract available
    
    
    
18. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    PubMed     Abstract available
    
    
    January 2025
19. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    PubMed     Abstract available
    
    
    
20. CRAIG N, Dweck MR
    Sociodemographic treatment trends for aortic stenosis since the adoption of transcatheter aortic valve intervention.
    Heart. 2025 Jan 16:heartjnl-2024-325328. doi: 10.1136/heartjnl-2024-325328.
    PubMed    
    
    
    
21. DONAL E, Gegout L, Bourg C
    Reassessing the role of tricuspid valve surgery in the modern era.
    Heart. 2025 Jan 16:heartjnl-2024-325476. doi: 10.1136/heartjnl-2024-325476.
    PubMed    
    
    
    December 2024
22. LIU R, Fu Z, Yan Y, Xie M, et al
    New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
    PubMed     Abstract available
    
    
    
23. DOEDENS A, Skarp S, Holmstrom L, Pakanen L, et al
    Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
    Heart. 2024;111:55-61.
    PubMed     Abstract available
    
    
    
24. PLAYFORD D, Stewart S, Harris SA, Scalia G, et al
    Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography.
    Heart. 2024 Dec 20:heartjnl-2024-324790. doi: 10.1136/heartjnl-2024-324790.
    PubMed     Abstract available
    
    
    
25. HADJI-TURDEGHAL K, Petersen JK, Graversen PL, Butt JH, et al
    Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
    Heart. 2024 Dec 20:heartjnl-2024-324803. doi: 10.1136/heartjnl-2024-324803.
    PubMed     Abstract available
    
    
    
26. GWAK SY, Kim K, Lee HJ, Cho I, et al
    Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk.
    Heart. 2024 Dec 17:heartjnl-2024-324891. doi: 10.1136/heartjnl-2024-324891.
    PubMed     Abstract available
    
    
    
27. YONES E, Gunn J, Iqbal J, Morris PD, et al
    Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review.
    Heart. 2024 Dec 12:heartjnl-2024-324802. doi: 10.1136/heartjnl-2024-324802.
    PubMed     Abstract available
    
    
    
28. DIGREGORIO H, Mansoorshahi S, Carlisle SG, Tovar Pensa C, et al
    Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve.
    Heart. 2024 Dec 10:heartjnl-2024-324669. doi: 10.1136/heartjnl-2024-324669.
    PubMed     Abstract available
    
    
    November 2024
29. SINGH A, Chalmers F, Aslam S, Bolton T, et al
    Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.
    Heart. 2024 Nov 27:heartjnl-2024-324918. doi: 10.1136/heartjnl-2024-324918.
    PubMed     Abstract available
    
    
    
30. DONAL E, Rouleau L
    Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches.
    Heart. 2024 Nov 7:heartjnl-2024-325097. doi: 10.1136/heartjnl-2024-325097.
    PubMed    
    
    
    
31. BJORN R, Strom JB, Lloyd G, Bhattacharyya S, et al
    Asymptomatic severe degenerative mitral regurgitation.
    Heart. 2024 Nov 7:heartjnl-2024-324739. doi: 10.1136/heartjnl-2024-324739.
    PubMed     Abstract available
    
    
    October 2024
32. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    PubMed     Abstract available
    
    
    September 2024
33. LAI FY, Gibbison B, O'Cathain A, Akowuah E, et al
    Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019).
    Heart. 2024 Sep 3:heartjnl-2024-324292. doi: 10.1136/heartjnl-2024-324292.
    PubMed     Abstract available
    
    
    August 2024
34. GALLI E, Le Ven F, Coisne A, Sportouch C, et al
    Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).
    Heart. 2024 Aug 28:heartjnl-2024-324224. doi: 10.1136/heartjnl-2024-324224.
    PubMed     Abstract available
    
    
    
35. JAHANGIRI M, Prendergast B
    Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
    Heart. 2024 Aug 7:heartjnl-2024-324054. doi: 10.1136/heartjnl-2024-324054.
    PubMed     Abstract available
    
    
    June 2024
36. RHEE TM, Kim HK
    Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:931-932.
    PubMed    
    
    
    
37. AKITA K, Kageyama S, Suzuki S, Ohno K, et al
    Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:954-962.
    PubMed     Abstract available
    
    
    
38. KLADOU E, Kochiadakis G, Hamilos M
    Unexpected finding on imaging: an aortic valve mass.
    Heart. 2024;110:939-970.
    PubMed    
    
    
    April 2024
39. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
    Sarcopenia and aortic valve disease.
    Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
    PubMed     Abstract available
    
    
    March 2024
40. BIEROWSKI MJ, Warner ED, Edirisuriya CD
    Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
    Heart. 2024;110:507-540.
    PubMed    
    
    
    February 2024
41. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    PubMed     Abstract available
    
    
    
42. TA S, Li J, Hsi DH, Hu R, et al
    Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
    PubMed     Abstract available
    
    
    January 2024
43. WACHTELL K
    Understanding the driving mechanisms of bioprosthetic valve degeneration.
    Heart. 2024;110:223-224.
    PubMed    
    
    
    
44. GUAL-CAPLLONCH F, Pericas P
    Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
    Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
    PubMed    
    
    
    December 2023
45. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    PubMed     Abstract available
    
    
    
46. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
    Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
    PubMed     Abstract available
    
    
    
47. PAVON AG, Guglielmo M
    Carcinoid heart disease: another step into the knowledge of a rare disease.
    Heart. 2023;110:79-80.
    PubMed    
    
    
    
48. MONDAL S, Kumar SS, Kesavan V
    Case of presyncope with mitral regurgitation.
    Heart. 2023;110:18-74.
    PubMed    
    
    
    
49. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available
    
    
    
50. JANDER N, Minners J
    Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
    Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
    PubMed    
    
    
    
51. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    PubMed     Abstract available
    
    
    November 2023
52. HAZEBROEK MR, Verdonschot JAJ
    One step closer to the new frontiers of healthcare for cardiomyopathy patients.
    Heart. 2023;109:1808-1810.
    PubMed    
    
    
    
53. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
    Relationship between the aortic root and the atrioventricular conduction axis.
    Heart. 2023;109:1811-1818.
    PubMed     Abstract available
    
    
    
54. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
    Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
    Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
    PubMed    
    
    
    
55. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
    Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
    Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
    PubMed     Abstract available
    
    
    
56. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available
    
    
    
57. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available
    
    
    
58. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
    Morphology of the mural and commissural atrioventricular junction of the mitral valve.
    Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
    PubMed     Abstract available
    
    
    
59. TOMASELLI M, Badano LP, Muraru D
    Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
    Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
    PubMed    
    
    
    
60. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
    Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
    Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
    PubMed     Abstract available
    
    
    October 2023
61. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed     Abstract available
    
    
    
62. YE Z, Clavel MA, Foley TA, Pibarot P, et al
    Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
    Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
    PubMed     Abstract available
    
    
    
63. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available
    
    
    
64. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
    Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
    Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
    PubMed     Abstract available
    
    
    
65. OTTO CM, Bartkowiak J, Hahn RT
    Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
    Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
    PubMed    
    
    
    
66. VEERARAGHAVAN S, Kidambi BR
    Sudden-onset breathlessness in a middle-aged man.
    Heart. 2023;109:1601-1650.
    PubMed    
    
    
    
67. DEMAL TJ, Conradi L
    Management of valve dysfunction in patients with mitral annular calcification.
    Heart. 2023;109:1639-1646.
    PubMed    
    
    
    September 2023
68. OTTO CM
    Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
    Heart. 2023;109:1419-1421.
    PubMed    
    
    
    
69. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    PubMed    
    
    
    
70. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    PubMed    
    
    
    August 2023
71. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
    Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
    Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
    PubMed     Abstract available
    
    
    
72. BARNES C, Sharma H, Gamble J, Dawkins S, et al
    Management of secondary mitral regurgitation: from drugs to devices.
    Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
    PubMed     Abstract available
    
    
    
73. JANG MH, Ahn JM, Kang DY, Kim KW, et al
    Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
    PubMed     Abstract available
    
    
    
74. XU Z, Gong C, Chen Y
    Patient in their 40s with unexplained myocardial hypertrophy.
    Heart. 2023;109:1280-1340.
    PubMed    
    
    
    
75. OTTO CM
    Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
    Heart. 2023;109:1263-1265.
    PubMed    
    
    
    
76. KUSUNOSE K, Ikemiyagi H
    Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
    Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
    PubMed    
    
    
    July 2023
77. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
    Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
    Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
    PubMed     Abstract available
    
    
    
78. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
    Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
    Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
    PubMed     Abstract available
    
    
    
79. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
    Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
    Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
    PubMed     Abstract available
    
    
    
80. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    PubMed     Abstract available
    
    
    
81. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    PubMed    
    
    
    
82. FARRANT J, Dodd S, Vaughan C, Reid A, et al
    Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:1175-1182.
    PubMed     Abstract available
    
    
    
83. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    PubMed     Abstract available
    
    
    
84. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
    Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
    Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
    PubMed     Abstract available
    
    
    June 2023
85. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    PubMed     Abstract available
    
    
    
86. COURTNEY WA, Schultz CJ, Hillis GS
    Aortic valve calcification and outcomes in severe aortic stenosis.
    Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
    PubMed    
    
    
    
87. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
    Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
    Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
    PubMed     Abstract available
    
    
    
88. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
    Recurrence of syncope after valve replacement in severe aortic stenosis.
    Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
    PubMed     Abstract available
    
    
    May 2023
89. PISLARU SV, Nkomo VT
    Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
    Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
    PubMed    
    
    
    
90. NIENABER CA, Yuan X, Nienaber SA
    Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
    Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
    PubMed    
    
    
    
91. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
    Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
    Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
    PubMed     Abstract available
    
    
    
92. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
    Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
    Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
    PubMed     Abstract available
    
    
    
93. HIBINO M, Pandey AK, Hibino H, Verma R, et al
    Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
    Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
    PubMed     Abstract available
    
    
    
94. OTTO CM
    Heartbeat: Choice of aortic valve intervention in younger adults.
    Heart. 2023;109:807-809.
    PubMed    
    
    
    
95. SHAH BN
    National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
    Heart. 2023;109:817-822.
    PubMed     Abstract available
    
    
    
96. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
    Matched comparison between external aortic root support and valve-sparing root replacement.
    Heart. 2023;109:832-838.
    PubMed     Abstract available
    
    
    
97. NUNES MCP, Barbosa JAA, Mocumbi A
    Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
    Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
    PubMed    
    
    
    
98. OH JK, Shen M, Guzzetti E, Tastet L, et al
    Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
    Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
    PubMed     Abstract available
    
    
    
99. LEEDY D, Elison DM, Farias F, Cheng R, et al
    Transcatheter aortic valve intervention in patients with cancer.
    Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
    PubMed     Abstract available
    
    
    
100. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
     Pregnancy-related aortic complications in women with bicuspid aortic valve.
     Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
     PubMed     Abstract available
     
     
     
101. SAN ROMAN JA
     Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
     Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
     PubMed    
     
     
     
102. VAN CAMP G
     Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
     Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
     PubMed    
     
     
     April 2023
103. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
     Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
     Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
     PubMed     Abstract available
     
     
     
104. OTTO CM
     Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
     Heart. 2023;109:725-727.
     PubMed    
     
     
     
105. RUBIS P
     Low-normal systolic function and hypertrophic cardiomyopathy.
     Heart. 2023;109:732-733.
     PubMed    
     
     
     
106. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
     Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
     Heart. 2023;109:771-778.
     PubMed     Abstract available
     
     
     
107. CRAMARIUC D, Urheim S
     Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
     Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
     PubMed    
     
     
     
108. RATWATTE S, Playford D, Stewart S, Strange G, et al
     Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
     PubMed     Abstract available
     
     
     
109. RATWATTE S, Stewart S, Strange G, Playford D, et al
     Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
     PubMed     Abstract available
     
     
     March 2023
110. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
     Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
     Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
     PubMed     Abstract available
     
     
     
111. OTTO CM
     Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
     Heart. 2023;109:573-575.
     PubMed    
     
     
     
112. BISWAS A, Shukla A, Kothari SS
     Typical effort angina in a tall adult.
     Heart. 2023;109:605-650.
     PubMed    
     
     
     
113. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
     Inflammatory and thrombotic valvulopathies in autoimmune disease.
     Heart. 2023;109:583-588.
     PubMed     Abstract available
     
     
     
114. MARON MS, Rowin E, Spirito P, Maron BJ, et al
     Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
     Heart. 2023;109:589-594.
     PubMed     Abstract available
     
     
     
115. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
     Perioperative care differences of surgical aortic valve replacement between North America and Europe.
     Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
     PubMed     Abstract available
     
     
     
116. GEERS J, Bing R
     Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
     Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
     PubMed    
     
     
     
117. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
     Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
     Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
     PubMed     Abstract available
     
     
     
118. ALI Z, Flynn AW
     Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
     Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
     PubMed    
     
     
     
119. OTTO CM
     Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
     Heart. 2023;109:495-497.
     PubMed    
     
     
     February 2023
120. KRIEGER EV, Burke CR, McCabe JM
     Sometimes mechanical, never routine: aortic valve replacement in young adults.
     Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
     PubMed    
     
     
     
121. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
     Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
     Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
     PubMed     Abstract available
     
     
     
122. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
     Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
     Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.